School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Hsiao-Yi Cheng in
Google Scholar
PubMed
Department of Primary Care Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
Search for other papers by Chun-Wei Liang in
Google Scholar
PubMed
Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Yu-Hao Lee in
Google Scholar
PubMed
Search for other papers by Timporn Vitoonpong in
Google Scholar
PubMed
Master’s Program in Long-Term Care, College of Nursing, Taipei Medical University, Taipei, Taiwan
Search for other papers by Chun-De Liao in
Google Scholar
PubMed
Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Shih-Wei Huang in
Google Scholar
PubMed
, hyaluronic acids, platelet-rich plasma (PRP), platelet rich in growth factor (PRGF), botulinum toxin A, O 2 –O 3 , dextrose, and mesenchymal stem cell (MSC). Regarding exercise, most studies included resistance training programs to strengthen the quadriceps
Search for other papers by Valentina Viglione in
Google Scholar
PubMed
Search for other papers by Angelo Boffa in
Google Scholar
PubMed
Search for other papers by Davide Previtali in
Google Scholar
PubMed
Search for other papers by Francesca Vannini in
Google Scholar
PubMed
Search for other papers by Cesare Faldini in
Google Scholar
PubMed
Department of Surgery, EOC, Service of Orthopaedics and Traumatology, Lugano, Switzerland
Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
Search for other papers by Giuseppe Filardo in
Google Scholar
PubMed
observed compared with the placebo group. Mansiz-Kaplan et al . ( 40 ) Injective Dextrose injection 33 3 months FFI, VAS-Activity, VAS-Rest Dextrose prolotherapy has efficacy up to 15 weeks and can be used as an alternative method in the
Search for other papers by Manuel Monteagudo in
Google Scholar
PubMed
Search for other papers by Pilar Martínez de Albornoz in
Google Scholar
PubMed
Search for other papers by Borja Gutierrez in
Google Scholar
PubMed
Search for other papers by José Tabuenca in
Google Scholar
PubMed
Search for other papers by Ignacio Álvarez in
Google Scholar
PubMed
rupture together with limited results are in contrast with the wide use of cortisone injections for PF worldwide. Other injection therapies that have also been shown to have short-term and variable benefits include hyperosmolar dextrose, botulinum toxin A
Sengkang General Hospital, Singapore
Joint first authors
Search for other papers by Hamid Rahmatullah Bin Abd Razak in
Google Scholar
PubMed
Joint first authors
Search for other papers by Daniel Chew in
Google Scholar
PubMed
Search for other papers by Zepur Kazezian in
Google Scholar
PubMed
Search for other papers by Anthony M.J. Bull in
Google Scholar
PubMed
vial of Anticoagulant Citrate Dextrose Solution Formula A (ACD-A). The first of the two devices is the nSTRIDE Cell Separator. It is a plastic tube containing a tuned-density buoy, which separates cellular and platelet components of whole blood to form
Search for other papers by Thomas Collins in
Google Scholar
PubMed
Search for other papers by Dinesh Alexander in
Google Scholar
PubMed
Search for other papers by Bilal Barkatali in
Google Scholar
PubMed
citrate dextrose-A (ACD-A) is the most commonly used in commercial kits. It maintains the optimal pH for platelets at 7.2 while the citrate binds to calcium preventing the coagulation cascade. They also recommend PRP be kept in small diameter tubes with